04/10/2024
6:17 PM | Annexon (Issuer)
Carson William H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
11:15 PM | Annexon (Filer)
| Form EFFECT | |
03/26/2024
4:01 PM | Annexon (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024
4:05 PM | Annexon (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/26/2024
3:05 PM | Annexon (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:10 PM | Annexon (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2024
2:12 PM | Annexon (Subject)
Overdorf Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/20/2024
2:12 PM | Annexon (Subject)
Lew Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:15 PM | Annexon (Subject)
Yednock Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
7:46 PM | Annexon (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
6:56 PM | Annexon (Issuer)
Love Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:59 PM | Annexon (Issuer)
Overdorf Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:52 PM | Annexon (Issuer)
Yednock Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:54 PM | Annexon (Issuer)
Lew Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:45 PM | Annexon (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
11:43 AM | Annexon (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:26 AM | Annexon (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
6:23 PM | Annexon (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:57 PM | Annexon (Subject)
Bain Capital Life Sciences Fund, L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024
2:39 PM | Annexon (Subject)
Yednock Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:40 PM | Annexon (Subject)
Lew Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:41 PM | Annexon (Subject)
Love Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:45 PM | Annexon (Subject)
Overdorf Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
6:02 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Annexon (Subject)
| Form SC 13G/A | |
01/23/2024
3:57 PM | Annexon (Issuer)
Lew Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:58 PM | Annexon (Issuer)
Overdorf Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:53 AM | Annexon (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
12/29/2023
3:12 PM | Annexon (Issuer)
Yednock Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:30 PM | Annexon (Issuer)
Annexon (Issuer)
Satter Muneer A (Reporting)
Satter Muneer A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:50 PM | Annexon (Subject)
Yednock Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:28 PM | Annexon (Filer)
| Form 8-K/A | |
12/20/2023
4:17 PM | Annexon (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
4:24 PM | Annexon (Subject)
| Form FWP | |
10/24/2023
3:30 PM | Annexon (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
3:44 PM | Annexon (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
7:36 AM | Annexon (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A | |
07/13/2023
2:37 PM | Annexon (Subject)
Lew Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
2:26 PM | Annexon (Subject)
Overdorf Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
2:31 PM | Annexon (Subject)
Yednock Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
12:25 PM | Annexon (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
06/12/2023
4:52 PM | Annexon (Issuer)
Satter Muneer A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This company has increased its dividend every year for 54 years (Ad) There are three basic steps to building the Ultimate Dividend Portfolio.
Step #1 is to Get The High Yields!
So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it.
But a company like Altria Group (MO) will. Click here to get them (for Free). |
06/12/2023
3:45 PM | Annexon (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:48 PM | Annexon (Issuer)
Cockroft Bettina M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:49 PM | Annexon (Issuer)
Choi Jung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:50 PM | Annexon (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
8:54 PM | Annexon (Issuer)
Bain Capital Life Sciences Fund, L.P. (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Partners, LP (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
8:55 PM | Annexon (Issuer)
Bain Capital Life Sciences Fund, L.P. (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Partners, LP (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/25/2023
5:08 AM | Annexon (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
